American depository receipts of European stocks were 1.1% lower at 121.78 on the Bank of New York Mellon Europe ADR Index on Monday morning.
Decliners in Continental Europe were led by Nabriva Therapeutics ( NBRV ), an Austria-based clinical-stage biopharmaceutical company, 4.7% lower, followed by Ascendis Pharma ( ASND ), a Danish clinical-stage biopharmaceutical company, down by 4.1% and VimpelCom - Com ( VIP ), a Dutch provider of telecommunications services, and Telecom Italia ( TI ), an Italian telecommunications company, both 3.0% lower.
In the UK, Amec Foster Wheeler ( AMFW ), a global engineering conglomerate, was 3.5% lower, followed by Amarin (AMRN), a biopharmaceutical company, and Barclays Bank (BCS), 3.4% and 3.1% lower, respectively.
Gainers in Continental Europe were led by Oasmia Pharmaceutical (OASM), a Sweden-based pharmaceutical company, 4.0% higher, followed by voxeljet (VJET), a German three-dimensional printer manufacturer, 1.9% higher and Trivago (TRVG), an online hotel search platform, up by 0.6%. RELX (RENX), a provider of information and analytics, was 0.2% higher.
And, in the UK, Motif Bio Plc - Warrant (MTFBW), a clinical-stage biopharmaceutical company, was 2.1% higher, followed by telecommunications company Vodafone Group (VOD), up by 1.2% and gold mining major Randgold Resources (GOLD), 0.7% higher. Midatech Pharma (MTP), an early-stage biopharmaceutical company, was 0.6% higher.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
